Prostate cancer decisions — 2020

The Veteran's claims for increased ratings and service connection were denied. The diabetes mellitus claim was denied as the symptoms did not meet the criteria for a higher rating, and the prostate cancer claim was denied due to lack of evidence of renal dysfunction or urinary tract infection. Service connection for peripheral neuropathy of the upper and lower extremities could not be established.

The Board denied service connection for kidney cancer and prostate cancer, both linked to Agent Orange exposure, due to insufficient evidence of a causal link between the conditions and active service.

The Board has remanded the Veteran's claims for prostate cancer and allergic rhinitis (chronic sinusitis) due to incomplete development. The cases will be reviewed again with additional opinions from medical experts.

The Board has remanded the Veteran's claims for a disability rating for back injury and service connection for prostate cancer due to pre-decisional duty to assist errors. The Veteran will need to undergo VA examinations to assess his back condition and determine if his prostate cancer is related to military service.

The Board denied the Veteran's claim for service connection for prostate cancer, attributing it to a lack of evidence showing that the condition had its onset in service or was related to exposure to contaminated water at Camp Lejeune.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicide agents during his service in the Republic of Vietnam.

The Board has remanded the claims for service connection for prostate cancer and right knee disorder due to insufficient evidence. The claim for hearing loss is also remanded, but the decision on whether it was incurred in service remains pending.

The Veteran's prostate cancer is not related to his service, including exposure to ionizing radiation. The Board denied the claim for service connection.

The Veteran's claim for service connection for prostate cancer was denied, and the Board found no basis to grant an earlier effective date.

The Veteran's claim for service connection for prostate cancer as associated with Agent Orange exposure is denied.,The Veteran's claim for service connection for erectile dysfunction secondary to prostate cancer is also denied.

The Board has granted an earlier effective date of September 6, 2013 for a 100 percent rating for service-connected prostate cancer. The claims for compensable ratings for ED, residuals of malaria, and throat disorder are denied.

The Board has remanded the case due to new evidence and need for a VA examination.

The Veteran's claim for service connection for diabetes mellitus type II is denied as there is no current diagnosis of the condition.,The Veteran's residuals of prostate cancer are rated at 20 percent, which is the maximum schedular rating available under Diagnostic Code 7528.

The Board has remanded the claims for prostate cancer, erectile dysfunction, and SMC due to loss of use of a creative organ. The remand is in response to an August 2020 Joint Motion for Partial Remand (JMR) where the Parties requested that the Veteran's military pay records be obtained to verify his claimed Vietnam service.

The Veteran's service-connected disabilities do not preclude him from obtaining and maintaining all forms of substantially gainful employment, so his claim for a total disability rating based on individual unemployability is denied.

The Veteran's prostate cancer is not service-connected due to lack of exposure to herbicide agents and no evidence of in-service or post-service continuity of symptoms.,Erectile dysfunction is not service-connected as it is not related to a service-connected disability.

The Board has restored service connection for prostate cancer, finding that the original decision was not clearly and unmistakably erroneous due to herbicide exposure at Udorn RTAFB in Thailand.

The Board has determined that the Veteran does not have a current diagnosis of residuals of lung cancer, prostate cancer, type 2 diabetes, kidney cancer, colon cancer, or monoclonal gammopathy. The claims for these conditions are therefore denied.

The Veteran's prostate cancer residuals are rated at a 40 percent rating effective October 18, 2019. The decision grants the claim for a higher disability rating.

The Veteran's prostate cancer and erectile dysfunction were not found to be related to his military service or a service-connected condition, leading to the denial of both claims.